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Abstract
Infection with Brucella canis has been diagnosed in Sweden for the first time. It was diagnosed in a three-year-old
breeding bitch with reproductive disturbances. Fifteen in-contact dogs were tested repeatedly and all of them
were negative for B. canis. The source of infection could not be defined. The present article describes the case and
the measures undertaken and gives a short review over B. canis. Recommendations on how to avoid the infection
in non-endemic countries are given.
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Background
Until 1994, Sweden had a quarantine requirement for all
dogs entering from abroad, except for dogs from Norway.
Norwegian dogs were allowed to enter without any
requirements at all since Norway has had the same epide-
miological status as Sweden for several decades. From
1994 to 2004, however, dogs from EU and EFTA countries
were allowed entry without quarantine if in possession of
an identity mark, rabies vaccination, rabies antibody titre
control and certain other prophylactic treatments. An
import license, amongst other documentation, was
required. In 2004, the new European pet regulation 998/
2003 came into effect allowing entry in combination with
certain national requirements. For dogs from EU and
EFTA countries only identity marking, rabies vaccination,
rabies antibody testing, deworming and a pet passport was
needed. These changes in regulations facilitated travelling
of dogs between Sweden and other European countries,
especially those within the European Union (EU). In addi-
tion, it led to an increased responsibility for dog owners to
protect their travelling dogs against unfamiliar infections
that did not exist in Sweden.
Dogs travel with their owners for varying reasons,
such as holiday, dog shows or breeding. The number of
litters that are registered within the Swedish Kennel
Club from a stud dog that is not registered in Sweden
or Norway has increased since 1994, and is today
around 8% of the total number of litters born, or
approximately 1000 litters per year (Figure 1). Breeding
leads to a special risk for transmission of infectious dis-
eases due to the close contact between the pair during
mating. Brucella canis is of special concern for breeding
dogs, since it can be transmitted venereally and cause
reproductive problems. There are reports that dogs can
also be infected with other Brucella species: Brucella
melitensis [1], Brucella suis [2] and Brucella abortus [3],
b u ti ti so n l yB. canis that is of epidemiological impor-
tance to the canine population.
Prevalence of B. canis
Infection with B. canis is common in Central and South
America and in southern USA [2,4] and has also been
reported from Canada [5,6]. In the USA, the dog trade
has led to a spread of the infection, and a growing need
for regulatory tools has been addressed [7]. In Georgia,
infection of dogs with B. canis was notable in 2003, and
a control strategy for the infection developed [8]. In
Asia the infection has been described and studied in
Japan [9,10], and it has also been reported from India
[11], the Philippines [12], Korea [13], China [14], Malay-
sia [15] and Taiwan [16], and in Africa from Nigeria
[17]. The number of described cases from central
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canis is neither notifiable to the World Organisation for
Animal Health (OIE) nor to the EU. Stray dogs in the
Mediterranean area are suggested to serve as a reservoir
[18,19]. In recent years, the number of published reports
on B. canis infection has increased. In Finland the infec-
tion has been diagnosed from dogs that were imported
from Russia [20]. The first outbreak in Hungary of B.
canis in a kennel was recently described [21], and cases
in male dogs are reported from Italy and Germany
[22,23]. Infection with B. canis was recently described in
three poodle bitches in a kennel in Austria [24]. Earlier
cases in Austria were a mongrel dog from Greece and a
purebred male dog [24]. Antibodies to both B. abortus
and B. canis have been described in a male dog in
Poland [3]. There has been serological evidence that B.
canis is present in Great Britain [25], Germany [26-28],
Italy [29] and Spain [19]. One case from Great Britain is
reported in a dog that was imported from Spain [30]. In
a dog shelter in Turkey, 4 out of 48 dogs (8%) that had
died of unknown reason were found to be infected with
B. canis [18]. In Europe, infection with B. canis has also
been reported in laboratory dogs in former Czechoslova-
kia [31] and from a kennel in France [32]. A schematic
drawing of prevalence of B. canis is shown in Figure 2.
Pathogenesis
B. canis enters the body via the mucosal membranes of
the oropharynx, genital tract or conjunctiva [33,34]. The
bacteria are then phagocytised by macrophages and
other phagocytic cells, and transported via the blood to
lymph nodes, spleen and genital organs, where they
multiply [33]. Hyperplasia of the lymphoid tissue is seen
throughout the body [35]. Bacteremia occurs 1 to 4
weeks after the infection and persists for at least 6
months, and then reoccurs intermittently for up to 5
years [36].
Clinical signs
The most typical clinical sign is late-pregnancy abortion,
week 7-9, [37], and this was the first sign described to
be related to infection with Brucella canis when the bac-
terium was first recognized, in 1966 [38]. Aborted pups
are partially autolysed and show signs of a generalised
bacterial infection, such as subcutaneous oedema,
abdominal hemorrhages, and degenerative lesions in
liver, kidneys, spleen and intestines. The bitch continues
to excrete a brownish or green-gray discharge for 1-6
weeks after the abortion [37]. Sometimes early embryo-
nic death and resorption occurs. Weak pups may die
within a few hours, but other times may survive up to a
month. Seemingly normal pups can also be born, and
develop the disease later [33]. Before puberty, a general-
ised lymphadenopathy is the most common clinical sign.
Brucellosis does not affect the oestrous cycle, and
bitches that have aborted can give birth to normal litters
in a subsequent pregnancy, or have intermittent repro-
ductive disturbances [33].
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Figure 1 The proportion of litters registered from stud dogs not registered in Sweden or Norway (per cent of total number of litters
registered in Sweden).
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Page 2 of 9In male dogs, epididymitis and prostatitis are the most
common clinical signs. In the acute stage, the epididy-
mis increases in size and is painful. Frequent licking
may lead to scrotal oedema and dermatitis. In the
chronic phase the epididymides may become small and
hard, and the testicle atrophic. Orchitis and ulcerative
scrotum dermatitis can be seen [39]. Chronically
infected dogs are often oligo- or azoospermic, and infer-
tile. Sperm defects that can be seen include tail defects,
loose heads and distal droplets [40]. In the testicles,
tubuli are fibrosed [41]. The testicular damage leads to
production of auto-antibodies towards the sperm cells.
These antibodies can be detected in serum and seminal
plasma from three months after the infection [42,43].
From 4 months after infection the sperm cells autoag-
glutinate [42].
Most often there are no general clinical signs, and
infected dogs do not usually have a fever. Sometimes
the dogs have a dull coat, or show decreased exercise
tolerance, but this is not common [44]. Lymphadenopa-
thy of the retropharyngeal or inguinal lymph nodes, or
generalised lymphadenopathy sometimes occurs [33].
Discospondylitis has been reported [45,46]. Dogs that
were experimentally infected with B. canis often showed
recurrent uveitis for several months after the infection
[40] and there are several case reports describing ocular
signs, such as endophthalmitis and anterior uveitis, in
dogs infected with B. canis [47-49]. Osteomyelitis
related to hip prostheses has been described in two dogs
[50]. Chronic meningitis and non-suppurative encephali-
tis has been associated with bacteria belonging to the
genus Brucella [33].
Diagnosis
The diagnosis is made by culture, polymerase chain
reaction (PCR) or serology, often in combination. To
make a definitive diagnosis by bacterial culture, the dog
should not be treated with antimicrobials. Blood culture
can be used, but often genital samples are better, espe-
cially if the dog shows clinical signs of the genital tract.
B. canis may be cultured from semen and vaginal dis-
charges during oestrus or after abortion and a high con-
centration of the infecting agent can be found in the
placenta. Urine cultures can be positive even if a blood
culture is negative. The highest urine concentration is
seen 8-12 weeks after infection, with the concentration
in urine being higher from male dogs than from bitches
[51]. The organs most suitable for culture, from biopsies
or at post mortem examination, are lymph nodes, pros-
tate and spleen [26]. PCR-analysis of whole blood has a
high sensitivity, whereas serum is not suitable for PCR
analysis [52]. Semen can be analysed with PCR [53,54].
P C Rc a nb eam o r es e n s i t i v em e t h o dt h a nb a c t e r i a lc u l -
ture because it detects not only viable but also dead
bacteria, and because the method is not affected by con-
tamination with other bacteria [55].
For screening, serologic tests are used. A rapid slide
agglutination test, RSAT, is commonly used, although a
drawback to this method is the risk of false positive
samples. By treating the sample with 2-mercapto-etha-
nol (2-ME) the number of false positive samples
decreases [19,56] because IgM is dissociated and IgM
cross-reacts with other bacteria more commonly than
IgG [57]. The agar gel immunodiffusion (AGID) test has
been described as suitable if a chronic infection is
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Figure 2 Geographical distribution of B. canis, clinical cases and seropositive dogs. A: Reports (including serosurveys) indicate that the
infection is endemic. B: Few clinical cases or outbreaks in kennels have been described C: Serosurveys indicate that the seroprevalence is low.
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Page 3 of 9suspected, because more chronic infections are positive
using an AGID than using other tests [36]. However,
the AGID is not used by many laboratories today
because of its low sensitivity and because it requires
trained personnel and special media [8]. Enzyme-linked
immunosorbent assays (ELISA) have been developed
[58] and a lateral flow immune-chromatographic assay
(LFIA) has recently been described [59]. A combination
of different serological tests is often recommended.
Treatment
Different antibiotics have been effective against B. canis
in in vitro studies [1,60], but multiresistant strains have
also been described [61]. Treatments that have been
evaluated include 1-3 weeks of combinations of different
antibiotics such as streptomycin, tetracycline, rifampicin
and sulphonamides [62,63], two weeks’ treatment each
with tetracycline, followed by dihydrostreptomycin and
trimetoprim-sulfadiazine [64], or 30 days of treatment
with enrofloxacin [65]. Clinically, no antibiotic treatment
has been shown to eliminate the infection in all treated
animals. If B. canis is diagnosed in a kennel, the affected
animal should be isolated and not used for breeding.
The environment should be thoroughly cleaned and dis-
infected. Since an infected dog, even if it is clinically
healthy, can infect other dogs and humans, euthanasia is
often recommended.
Transmission
Dogs are most commonly infected by contact with vagi-
nal discharges at oestrous or after abortions, or by
ingesting infected placentas or foetuses. At abortion, the
placenta and the discharges can contain up to 10
10 col-
ony forming units (cfu) per mL, and the oral infection
dose is 2 × 10
6 cfu. Experimentally, 10
4 cfu has been
sufficient for conjunctival infection [34,40,66]. Thus, 1
mL placental tissue or vaginal discharge is equal to
approximately 100 000 infectious doses, and the bitches
can have a vaginal discharge for up to 6 weeks after an
abortion. Dogs can also be infected at mating. It should
be observed that chronically infected dogs can be serolo-
gically negative and negative on blood culture, although
B. canis can be detected from the prostate, epididymis
and semen, or in female dogs in vaginal secretion, and
thus they can still infect other dogs at mating or via
artificial insemination [36,54,67].
Environmental infection is possible, especially from
areas where dogs often urinate [34], or where vaginal dis-
charges are deposited. Dogs living together are at risk of
infecting each other. Within half a year, infected male
dogs had infected other male dogs, and bitches had
infected other bitches [51]. It was suspected that con-
taminated urine was an important source of infection in
these cases, especially from male dogs. The concentration
of bacteria in urine and semen is highest from 1 to 4-6
months after infection [51].
Recommendations to avoid introduction of B. canis into
non-endemic areas
To avoid introducing brucellosis into a kennel, the
introduction of untested dogs from endemic areas
should be avoided. Dogs from kennels in which B. canis
has been diagnosed should not be used for breeding
(Table 1). Dogs from endemic areas should be kept iso-
lated until tested free of B. canis to avoid further spread
of the disease. This is recommended for natural mating,
artificial insemination with fresh, chilled or frozen
semen, and when introducing new dogs into the ken-
nels. For kennels in endemic areas it is often recom-
mended that breeding animals are tested annually, and
that all new dogs are tested before being introduced
into the kennel. Serologic tests can be negative up to 4
weeks after infection, and at least 12 weeks must pass to
be sure of detecting antibodies in an infected animal
[36]. Therefore, two negative tests 4-6 weeks apart are
needed in case the dog is incubating the disease [8]. At
least one of the sampling occasions should be no earlier
than 12 weeks after suspected contact with an infected
animal. Bitches that might be chronically infected
should be tested during oestrus, pregnancy or at abor-
tion, as they may have low antibody titres at other times
[44]. Chronically infected male dogs can also be difficult
to detect, as they too can be serologically negative. In
addition to serologic methods, bacterial culture or PCR
analysis can be performed to detect the bacterium. Only
dogs tested free from B. canis should be used for breed-
ing, and recommended tests depend on the level of risk
(Table 1).
If B. canis is detected in a group of dogs, regular test-
ing and removal of infected dogs and strict hygiene is
necessary to eradicate the infection [28]. Common disin-
fectants are effective against B. canis.
Infection with B. canis in humans
Humans can become infected with B. canis, although
reported cases are scarce. The clinical presentation is
unspecific, including fever (as opposed to the disease in
dogs), headache and fatigue, and a history of exposure
to dogs is usually needed to raise suspicion of infection
with B. canis [68]. The infection may be underdiagnosed
due to its rather unspecific symptoms. Positive blood
cultures confirm the diagnosis, but as the patients have
been treated with antibiotics in many cases, the risk of a
false negative culture is increased [69]. Furthermore, B.
canis is slow-growing and mildly fastidious, producing
low-grade bacteremias, decreasing cultural sensitivity
[68]. Serodiagnosis is problematic due to a lack of anti-
genic cross-reactivity with the antigens routinely used,
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despite positive blood culture has also been described
[70]. Treatment with antibiotics is usually effective in
humans.
There are several reports on disease in humans with-
out immune disorders. A 17-month old boy had refusal
to walk as the chief symptom [71]. An outbreak with
fever, diarrhoea and vomiting in children and headache,
fatigue, myalgia and nausea in adults has been described
[ 7 2 ] .F e v e r ,f a t i g u e ,a n dnausea are common clinical
signs [73,74]. A man with endocarditis was serologically
positive for B. canis although the source of infection
could not be established [75]. A fifteen year old boy suf-
fered from weakness, persistent fever and lymphadeno-
pathy [76]. Sometimes relapses and more prolonged
courses of illness are described [69].
Clinical infection with B. canis has also been reported
in persons with immune disorders. Signs such as fatigue,
fever, malaise, headache, cough and arthralgia have been
described [77,78].
Case presentation
In December 2010, a 3-year-old American Staffordshire
terrier imported from Poland, expecting her first litter,
was brought to the Regional Animal Hospital of Hel-
singborg, Sweden. She was 46 days pregnant but
although her general condition was good, she had a
green vaginal discharge. An ultrasonography was per-
formed which revealed that all pups were dead. The
bitch was aborted with aglepristone and prostaglandins,
and also received amoxicillin. Hematology showed mild
leukocytosis and moderate eosinophilia. Bacterial culture
from the vagina showed no bacterial growth. The bitch
was monitored with ultrasonography and clinical exami-
nations for the following weeks. Her general condition
was good and the discharge ceased rapidly. No foetal
parts could be identified in the discharge.
In the follow-up of the abortion the owner reported
that the bitch had been mated in Poland, and that she
had been mated once previously with a dog from Serbia,
although she did not conceive at the time. This led to
the suspicion of brucellosis, and the bitch was tested
serologically for B. canis in January 2011, with a nega-
tive result. An analysis for Giardia and a Baermanns flo-
tation test for parasites were also negative. The owner
was recommended to vaccinate the bitch against canine
herpesvirus at the next mating, and to follow progester-
one levels during the next pregnancy.
In the end of May 2011 the bitch was again presented
at the animal hospital. She had been taken to Poland
f o rm a t i n gt ot h es a m ed o ga g a i n ,a n dn o wh a da
bloody discharge at day 59 of pregnancy. Ultrasonogra-
phy was performed and all but one pup were dead. A
caesarean section was performed, but no pups were
alive. Ten dead, partially autolysed pups were delivered.
The uterus was filled with a brown-greenish discharge
and all pups had cutaneous ulcerations. The bitch was
treated with amoxicillin and cabergolin, and recovered
uneventfully. This second abortion in the last trimester
in a clinically healthy bitch mated abroad again raised
the suspicion of brucellosis, and the placentae from
aborted foetuses were sent to the National Veterinary
Institute (SVA) for bacteriological analysis, specifically
asking for B. canis.
The culture result from the placentae was positive. As
this was the first case of B. canis in Sweden, the strain
was sent to EU-RL (European Union Reference Labara-
tory) in Alfort, France, for confirmation. The bitch was
also tested serologically, and was now positive for B.
canis. The Swedish Board of Agriculture (JV) decided
that the bitch had to be isolated until a definitive diag-
nosis was made (confirmation by EU-RL); they initiated
contact tracing and contacted the county veterinarian
and the county medical officer. The bitch was tested
again by blood culture, vaginal culture and serology
(RSAT). B. canis grew in the blood culture and in the
vaginal culture, and the bitch still had antibodies to B.
canis. The first bacteriological culture was confirmed by
the EU-RL. The Swedish Board of Agriculture decided
that the bitch should be euthanized, as recommended
by SVA. The bitch was euthanized at the Regional Ani-
mal Hospital of Helsingborg.
Table 1 Recommendations for testing dogs from areas endemic for B. canis when mated or inseminated with dogs
from non-endemic areas, or when imported to non-endemic areas
Risk
level
Situation Recommended test
1 Mating or insemination, no suspicion of B. canis and no reproductive
disturbances
Blood sample for antibody analysis
2 Mating or insemination with dog with previous reproductive disturbances,
import of dogs without reproductive disturbances.
Serology: 2 samples 4-6 weeks apart
3 Import of or mating/insemination with dogs with previous reproductive
disturbances, infection with B. canis suspected.
Serology, 2 samples 4-6 weeks apart, blood culture and
culture or PCR from semen or vagina
4 Import of or mating/insemination with dog from kennel with endemic infection
of B. canis.
Dissuaded from mating or import.
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SVA recommended how and which dogs to test, and JV
had the main responsibility for the contact tracing. Dogs
within the country that had been in contact with the
infected bitch through mating, common housing or
other close contact, were tested. All in-contact dogs
were tested twice, with cultures from blood and the gen-
ital tract, and by serology. At least one of the occasions
should be minimum 12 weeks after the latest risk con-
tact. At least one sample from the genital tract should
be during oestrus in bitches, and semen was cultured
from the male dogs.
Possible sources of infection included the two dogs
that had mated the bitch. The first dog that had
mated the bitch, when she did not conceive, had been
sold to Sweden by this time and was a stud dog in
northern Sweden. There was a history of bitches not
conceiving after mating with him. A semen sample in
October 2010 revealed azoospermia, macrophages and
epithelial cells in the small ejaculate of 1 mL. In July
2011 the total sperm count was 115 million, with 60%
sperm having various unspecified defects and an abun-
dance of epithelial cells. Two months later, in Septem-
ber, the total sperm count was 1265 million, 75%
progressive motility and 10% unspecified defects. In
November 2011 a new semen sample was taken and
evaluated. The total number of sperm was good (1700
million), their motility was good and defects were
within normal limits. Epithelial cells and leukocytes
were also within normal limits. He was tested for B.
canis in July, September and November 2011 by blood
and semen culture and by serology (RSAT), and in
November semen was also analysed by PCR. In-con-
tact dogs to this male dog were tested in the same
way as in-contact dogs to the bitch. In total, 15 in-
contact dogs of different breeds were tested with no
test results being positive. The contact tracing is sche-
matically described in Figure 3.
In Poland, the male that mated the bitch the second
and third time was serologically tested (RSAT) twice
during the autumn 2011, with negative results, and he is
still being used for breeding in Poland. He resides in a
kennel. The Brucella status of the other dogs is not
known.
Discussion
The bitch was imported as a young dog to Sweden from
Poland. The first male dog that she was mated to, from
Serbia, has a history of bitches not conceiving after mat-
ing, including the present bitch. There are several causes
for bitches not to conceive, including poor semen qual-
ity due to infection with B. canis. This male dog has
been included in the contact tracing as he now resides
in Sweden.
At the second and third mating, a male dog from
Poland was used. The bitch conceived after both these
matings, but aborted late in pregnancy, which is typical
for infection with B. canis [44]. Autolysed pups with
subcutaneous hemorrhages are typical and could be
seen in the present case. The vaginal discharges had a
short duration, possibly due to the fact that the bitch
was treated with amoxicillin after both abortions.
The bitch was serologically negative for B. canis in
January 2011, after the first abortion. More than 12
weeks had passed since the bitch mated the first male
dog, and 11 weeks since she mated the second male,
from Poland. In addition she was sampled close to an
abortion, which stimulates antibody production in
chronically infected bitches. No bacterial cultures were
carried out at this occasion. The suspicions were direc-
ted against the male dog from Serbia, because bitches
had failed to conceive after mating with him, whereas
the other male dog had sired healthy litters. Extensive
testing of the imported dog from Serbia has been car-
ried out, and all results were negative for B. canis.H i s
semen quality, although previously was poor, has nor-
malised. The second male dog has been tested twice by
serology, and also found negative. The source of infec-
tion for the bitch could thus not be established.
Brucellosis in food-producing animals in Sweden is
regulated by law and the costs for measures against the
disease, including compensation to the animal owner,
are paid by the government. The reasons for the govern-
ment to act to eradicate the infection in a dog were a
combination of the fact that B. canis is a zoonosis and
that a quick and reliable diagnosis is missing, thereby
making it difficult for owners to protect themselves and
their animals, should the infection be established within
the country. International experiences show that power-
ful measures, such as euthanasia of infected animals, is
often needed to eradicate the infection in kennels and
to stop further spread of the infection [8].
What are the consequences for the pet owners?
The diagnosis of B. canis in the bitch was a personal
tragedy to the owner. She lost her dog, money and
future pups. She was a small-scale breeder; in larger
kennels the economic consequences will be even bigger
as all breeding stock may be lost. The consequences
were considerable also for the owners of in-contact
dogs. They had to keep their dogs separate and bring
them to animal clinics or hospitals for sampling, and
could not use them for breeding until they were
declared free from B. canis.
Conclusions
A typical case of B. canis in a dog with reproductive dis-
turbances has been diagnosed in Sweden. Handling of
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rities is described. Results from the contact tracing indi-
cated that the infection most probably has not spread
within the country. The source of infection could not be
identified. Recommendations on how to avoid introduc-
tion of B. canis into non-endemic areas are given.
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